| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |